Sometimes the riskiest choice for a patient isn't the treatment. It's doing nothing.
Medical training spends a lot of time on the fear of causing harm through treatment, and comparatively little time weighing the harm caused by leaving a disease untreated. That imbalance has a name — the treatment-risk paradox — and IV iron is one of the clearest examples of it in practice.
"First, do no harm" was never supposed to mean "first, do nothing." Inaction is a decision too, and it carries its own risk profile.
What's the actual risk of IV iron?
True anaphylaxis with modern IV iron formulations is rare, reported at under 1 in 200,000 infusions, roughly 0.0005 percent. That's the number that tends to drive hesitation about treatment.
What's the risk of leaving iron deficiency untreated instead?
This is the side of the equation that gets far less attention. Leaving someone iron deficient for years, rather than treating it, carries its own well-documented consequences: persistent fatigue, depression, brain fog, and restless legs, among others.
There's also a specific, less commonly discussed consequence worth naming directly: iron deficiency is linked to infertility. Correcting it in women trying to conceive is associated with improved outcomes — higher live birth rates and lower rates of miscarriage in women being treated for iron deficiency related to infertility.
Zoomed out further, iron-deficiency anemia is one of the leading causes of years lived with disability among women globally. That's not a small-scale problem being weighed against a treatment risk. That's a massive, cumulative burden being weighed against a risk of roughly 1 in 200,000.
Why does the math feel backwards?
Because a treatment risk is specific, immediate, and easy to picture: a needle, an infusion, a possible reaction in that moment. The cost of inaction is diffuse, cumulative, and easy to attribute to something else entirely — stress, aging, "just being tired." That asymmetry in how vivid each risk feels is exactly why the treatment-risk paradox happens, even among well-intentioned clinicians.
What does this actually mean for you?
It means the question worth asking isn't just "what could go wrong with this treatment?" It also has to be "what happens if I don't do this, and how long does that continue?" For iron deficiency specifically, the honest answer to that second question is often years of avoidable symptoms and, for some, real reproductive health consequences, weighed against a treatment risk that's extremely small.
The bottom line
"First, do no harm" was never meant to justify inaction. Doing nothing has a risk profile too, and with iron deficiency, that risk profile is often bigger than the one attached to actually treating it. The goal isn't to ignore treatment risk. It's to weigh it honestly against the real cost of leaving a problem unaddressed.
